Bill Toll

Bill Toll is an experienced finance professional with a strong background in financial planning and analysis within the pharmaceutical and biotechnology sectors. Currently serving as Executive Director of Financial Planning & Analysis at Karyopharm Therapeutics Inc. since July 2015, Bill has held various leadership roles, including Senior Director and Director of R&D Finance, focusing on comprehensive financial management for research and development functions. Prior experience includes a Senior Manager role at Cubist Pharmaceuticals, where financial management encompassed Discovery and Non-Clinical Development, as well as several positions at AstraZeneca, where responsibilities included budgeting and cost analysis for both Manufacturing and R&D sectors. Bill's earlier roles in financial management began at Window Book, Inc. and Online Resolution, Inc. Bill holds an MBA in Finance from Boston College Carroll School of Management and a Bachelor’s Degree in Mathematics from Haverford College.